Howard Benjamin, VP Business Development at REPLIGEN CORP (RGEN), sold 25,458 shares at $35.34 ($900K) on 2017-12-14, disclosed to the SEC on 2017-12-18.
Open-market sale of $900k RGEN by VP Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.34 | 12,729 | $450K | 50.0% |
| 2 | $35.34 | 12,729 | $450K | 50.0% |
| Total | $35.34 avg | 25,458 | $900K | 100% |
| Filing → |
| RGEN | SELL | 2015-06-10 | $1.3M | — | Filing → |
| RGEN | SELL | 2015-03-19 | $515K | — | Filing → |
| RGEN | SELL | 2014-11-12 | $707K | — | Filing → |